Abstract Introduction: Since the coronavirus disease 2019 (COVID-19) outbreak in Wuhan in late 2019, controversy on the use of corticosteroids for COVID-19 has obtained increasing attention. We present 1 critically ill patient who had a rapid therapeutic response to moderate-dose corticosteroids. Patient concerns: A 53-year-old critically ill woman from Wuhan suffered with COVID-19. Diagnosis: The chest computed tomography scan was suggestive of COVID-19. The diagnosis was confirmed by a real-time reverse transcription polymerase chain reaction test for SARS-CoV-2. The critically ill status was characterized by worsening dyspnea, progressing bilateral lung consolidation, and poor oxygenation (SiO 2 /FiO 2 :110 mm Hg). Interventions: The patient was treated with a moderate dose of intravenous corticosteroids and high-flow nasal cannula oxygen therapy. Outcomes: After the initiation of corticosteroids, the patient rapidly improved over the following 6 days. Serial chest computed tomography scans showed good absorption of the consolidations. The patient was discharged on Day 17 of hospitalization without obvious adverse effects. Conclusions: Early use of moderate-dose corticosteroids over a short period may enhance recovery from COVID-19 in critically ill patients.
【저자키워드】 COVID-19, SARS-CoV2, Critically ill patient, corticosteroids use, 【초록키워드】 Corticosteroid, coronavirus disease, SARS-CoV-2, Corticosteroids, Hospitalization, Diagnosis, lung, nasal, adverse effects, Chest computed tomography, Critically ill, outbreak, Dyspnea, Wuhan, Patient, Oxygen therapy, reverse transcription, moderate, consolidation, critically ill patients, dose, intravenous, consolidations, worsening, therapeutic response, polymerase chain, ENhance, poor oxygenation, the patient, Day, characterized, treated, suffered, discharged, use of corticosteroid, with COVID-19, 【제목키워드】 Corticosteroid, Case report, Critically ill, patient with COVID-19,